Shigeki Shichijo

4.0k total citations
149 papers, 3.2k citations indexed

About

Shigeki Shichijo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Shigeki Shichijo has authored 149 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 70 papers in Molecular Biology and 44 papers in Oncology. Recurrent topics in Shigeki Shichijo's work include Immunotherapy and Immune Responses (96 papers), Immune Cell Function and Interaction (33 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Shigeki Shichijo is often cited by papers focused on Immunotherapy and Immune Responses (96 papers), Immune Cell Function and Interaction (33 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Shigeki Shichijo collaborates with scholars based in Japan, United States and United Kingdom. Shigeki Shichijo's co-authors include Kyogo Itoh, Akira Yamada, Nobukazu Komatsu, Masanori Noguchi, Hideaki Yamana, K Itoh, Masanobu Nakao, Masaru Hirohata, Koichi Takahashi and Kyogo Itoh and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Shigeki Shichijo

143 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeki Shichijo Japan 31 1.9k 1.5k 1.1k 298 267 149 3.2k
June Eisenman Canada 20 3.6k 1.8× 1.4k 0.9× 1.0k 0.9× 315 1.1× 528 2.0× 28 5.6k
Frank Grünebach Germany 38 2.4k 1.2× 1.8k 1.2× 1.3k 1.1× 193 0.6× 312 1.2× 73 4.2k
Kei‐ichi Shibahara Japan 20 1.6k 0.8× 2.4k 1.6× 1.8k 1.7× 138 0.5× 282 1.1× 28 4.8k
Atsuo Ochi Canada 29 2.0k 1.0× 895 0.6× 570 0.5× 337 1.1× 328 1.2× 53 3.1k
Sophie M. Lehar United States 18 2.7k 1.4× 1.3k 0.9× 644 0.6× 140 0.5× 247 0.9× 22 3.9k
John M. Herndon United States 26 2.6k 1.3× 1.2k 0.8× 1.5k 1.4× 212 0.7× 241 0.9× 44 4.2k
Nobuo Sakaguchi Japan 37 2.7k 1.4× 1.9k 1.3× 537 0.5× 514 1.7× 275 1.0× 119 4.7k
Dale Ando United States 30 2.3k 1.2× 2.3k 1.5× 1.3k 1.2× 440 1.5× 366 1.4× 55 5.4k
Giovina Ruberti Italy 24 1.3k 0.7× 1.6k 1.0× 388 0.4× 174 0.6× 299 1.1× 61 3.0k
J Wignall United States 13 2.8k 1.4× 1.4k 0.9× 745 0.7× 320 1.1× 346 1.3× 19 4.4k

Countries citing papers authored by Shigeki Shichijo

Since Specialization
Citations

This map shows the geographic impact of Shigeki Shichijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Shichijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Shichijo more than expected).

Fields of papers citing papers by Shigeki Shichijo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Shichijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Shichijo. The network helps show where Shigeki Shichijo may publish in the future.

Co-authorship network of co-authors of Shigeki Shichijo

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Shichijo. A scholar is included among the top collaborators of Shigeki Shichijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Shichijo. Shigeki Shichijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Shinjiro, Satoko Matsueda, Shinzo Takamori, et al.. (2017). Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11+ or ‐A33+ allele. Cancer Science. 108(4). 598–603. 4 indexed citations
2.
Matsueda, Satoko, Akira Yamada, Shigeki Shichijo, et al.. (2017). A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer. Cancer Science. 108(5). 838–845. 34 indexed citations
3.
Iwasa, Satoru, Yasuhide Yamada, Yuji Heike, et al.. (2016). Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients. Cancer Science. 107(5). 590–600. 10 indexed citations
4.
5.
Komatsu, Nobukazu, et al.. (2009). Identification of peptides applicable as vaccines for HLA‐A26‐positive cancer patients. Cancer Science. 100(11). 2167–2174. 5 indexed citations
6.
Komohara, Yoshihiro, Shigeki Shichijo, Mamoru Harada, et al.. (2008). Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients. Oncology Reports. 19(5). 1277–83. 15 indexed citations
7.
Komatsu, Nobukazu, Kyogo Itoh, Shigeki Shichijo, et al.. (2008). Dissection and identification of regions required to form pseudoparticles by the interaction between the nucleocapsid (N) and membrane (M) proteins of SARS coronavirus. Virology. 380(1). 99–108. 26 indexed citations
8.
Azuma, Koichi, Shigeki Shichijo, Hiroki Shomura, et al.. (2004). Identification of HER2/neu-Derived Peptides Capable of Inducing both Cellular and Humoral Immune Responses in HLA-A24 Positive Breast Cancer Patients. Breast Cancer Research and Treatment. 86(1). 19–29. 10 indexed citations
9.
Yutani, Shigeru, Masatoshi Tanaka, Michio Sata, et al.. (2002). Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis. Japanese Journal of Cancer Research. 93(4). 453–458. 2 indexed citations
10.
Nakao, Masanobu, Shigeki Shichijo, Toshihiro Imaizumi, et al.. (2000). Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL. The Journal of Immunology. 164(5). 2565–2574. 108 indexed citations
11.
Murayama, Kumiko, Toshihiro Imaizumi, Kazuko Matsunaga, et al.. (2000). Expression of the SART3 Tumor-Rejection Antigen in Brain Tumors and Induction of Cytotoxic T Lymphocytes by Its Peptides. Journal of Immunotherapy. 23(5). 511–518. 44 indexed citations
12.
Shichijo, Shigeki, Masanobu Nakao, Yasuhisa Imai, et al.. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. The Journal of Experimental Medicine. 187(3). 277–288. 184 indexed citations
13.
Matsumoto, Hajime, Shigeki Shichijo, Kouichiro Kawano, et al.. (1998). Expression of the SART‐1 Antigens in Uterine Cancers. Japanese Journal of Cancer Research. 89(12). 1292–1295. 8 indexed citations
14.
Shichijo, Shigeki, Tomoaki Hoshino, KIKUO KOUFUJI, et al.. (1997). Detection of MAGE‐4 Protein in Sera of Lung Cancer Patients. Japanese Journal of Cancer Research. 88(4). 414–419. 7 indexed citations
15.
Shichijo, Shigeki, et al.. (1996). Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine. Japanese Journal of Cancer Research. 87(7). 751–756. 24 indexed citations
16.
Kataoka, Akio, et al.. (1995). Expression of MAGE‐1, MAGE‐2, MAGE‐3/‐6 and MAGE‐4A/‐4B genes in ovarian tumors. International Journal of Cancer. 64(6). 388–393. 43 indexed citations
17.
Kotera, N., et al.. (1993). Effect of high molecular weight sodium hyaluronate(SL-1010) on human neutrophil function.. Ensho. 13(1). 55–61. 1 indexed citations
18.
Chichibu, Kenji, Takashi Matsuura, Shigeki Shichijo, & Mineyuki Yokoyama. (1989). Assay of serum hyaluronic acid in clinical application. Clinica Chimica Acta. 181(3). 317–323. 102 indexed citations
19.
Kajita, Tadahiro, et al.. (1987). Evaluation of matuhasi-ogata phenomenon using monoclonal antibodies.. Journal of the Japan Society of Blood Transfusion. 33(4). 399–408. 1 indexed citations
20.
Masuda, Hiroshi, et al.. (1977). Comparative studies on the gastric glycopeptide in eleven animal species. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 58(2). 163–165.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by June Eisenman Breakdown of academic impact, for papers by Frank Grünebach Breakdown of academic impact, for papers by Kei‐ichi Shibahara Breakdown of academic impact, for papers by Atsuo Ochi Breakdown of academic impact, for papers by Sophie M. Lehar Breakdown of academic impact, for papers by John M. Herndon Breakdown of academic impact, for papers by Nobuo Sakaguchi Breakdown of academic impact, for papers by Dale Ando Breakdown of academic impact, for papers by Giovina Ruberti Breakdown of academic impact, for papers by J Wignall
Rankless by CCL
2026